Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles

Abstract The advancement of neuroprotective pharmacological agents to proficiently avert amyloid-β (Aβ) clustering persists as a significant obstacle in Alzheimer’s disease (AD) management. This analysis focuses on the inhibitory characteristics related to amyloid formation of selenium nanoparticles...

Full description

Saved in:
Bibliographic Details
Main Authors: Shubhangi D. Shirsat, Chunyi Li, Zhipeng Liu, Varenyam Achal, Olivier Habimana
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-03962-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849434229281128448
author Shubhangi D. Shirsat
Chunyi Li
Zhipeng Liu
Varenyam Achal
Olivier Habimana
author_facet Shubhangi D. Shirsat
Chunyi Li
Zhipeng Liu
Varenyam Achal
Olivier Habimana
author_sort Shubhangi D. Shirsat
collection DOAJ
description Abstract The advancement of neuroprotective pharmacological agents to proficiently avert amyloid-β (Aβ) clustering persists as a significant obstacle in Alzheimer’s disease (AD) management. This analysis focuses on the inhibitory characteristics related to amyloid formation of selenium nanoparticles (SeNPs) enveloped in 5-caffeoylquinic acid (CQA), which are biosynthesized using violet sweet potato (PSP) extract. Engineered SeNPs revealed an absorption peak at 260 nm, were spherical and non-crystalline (50–60 nm), and had a zeta potential measured at 24.3 ± 2.1 mV. The antioxidant traits of SeNPs were showcased (IC50 = 8.01 ± 1.21 µg/mL), by obstructing AChE (IC50 = 3.70 ± 0.02 µg/mL) and BChE (IC50 = 72 ± 0.5 µg/mL), while also diminishing Aβ fibrillation, thereby emphasizing their function in the modulation of amyloid clustering. Molecular dynamics simulations elucidated that CQA-SeNPs preferentially associate with hydrophobic residues (e.g., Leu34 and Phe19) of the Aβ peptide, obstructing β-sheet formation. These findings suggest that CQA-SeNPs interfere with Aβ aggregation, offering a potential therapeutic strategy for AD.
format Article
id doaj-art-e16cb3d1c68d47aa84ecfb75ab8cfc93
institution Kabale University
issn 2045-2322
language English
publishDate 2025-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-e16cb3d1c68d47aa84ecfb75ab8cfc932025-08-20T03:26:44ZengNature PortfolioScientific Reports2045-23222025-06-0115111310.1038/s41598-025-03962-0Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticlesShubhangi D. Shirsat0Chunyi Li1Zhipeng Liu2Varenyam Achal3Olivier Habimana4Biotechnology and Food Engineering Program, Guangdong Technion-Israel Institute of TechnologyBiotechnology and Food Engineering Program, Guangdong Technion-Israel Institute of TechnologyBiotechnology and Food Engineering Program, Guangdong Technion-Israel Institute of TechnologyEnvironmental Engineering Program, Guangdong Technion-Israel Institute of TechnologyBiotechnology and Food Engineering Program, Guangdong Technion-Israel Institute of TechnologyAbstract The advancement of neuroprotective pharmacological agents to proficiently avert amyloid-β (Aβ) clustering persists as a significant obstacle in Alzheimer’s disease (AD) management. This analysis focuses on the inhibitory characteristics related to amyloid formation of selenium nanoparticles (SeNPs) enveloped in 5-caffeoylquinic acid (CQA), which are biosynthesized using violet sweet potato (PSP) extract. Engineered SeNPs revealed an absorption peak at 260 nm, were spherical and non-crystalline (50–60 nm), and had a zeta potential measured at 24.3 ± 2.1 mV. The antioxidant traits of SeNPs were showcased (IC50 = 8.01 ± 1.21 µg/mL), by obstructing AChE (IC50 = 3.70 ± 0.02 µg/mL) and BChE (IC50 = 72 ± 0.5 µg/mL), while also diminishing Aβ fibrillation, thereby emphasizing their function in the modulation of amyloid clustering. Molecular dynamics simulations elucidated that CQA-SeNPs preferentially associate with hydrophobic residues (e.g., Leu34 and Phe19) of the Aβ peptide, obstructing β-sheet formation. These findings suggest that CQA-SeNPs interfere with Aβ aggregation, offering a potential therapeutic strategy for AD.https://doi.org/10.1038/s41598-025-03962-0Selenium nanoparticles5‑caffeoylquinic acidAntioxidantCholinesteraseβ-Amyloid peptideMolecular dynamic simulation
spellingShingle Shubhangi D. Shirsat
Chunyi Li
Zhipeng Liu
Varenyam Achal
Olivier Habimana
Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
Scientific Reports
Selenium nanoparticles
5‑caffeoylquinic acid
Antioxidant
Cholinesterase
β-Amyloid peptide
Molecular dynamic simulation
title Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
title_full Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
title_fullStr Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
title_full_unstemmed Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
title_short Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles
title_sort anti amyloidogenic properties of 5 caffeoylquinic acid capped selenium nanoparticles
topic Selenium nanoparticles
5‑caffeoylquinic acid
Antioxidant
Cholinesterase
β-Amyloid peptide
Molecular dynamic simulation
url https://doi.org/10.1038/s41598-025-03962-0
work_keys_str_mv AT shubhangidshirsat antiamyloidogenicpropertiesof5caffeoylquinicacidcappedseleniumnanoparticles
AT chunyili antiamyloidogenicpropertiesof5caffeoylquinicacidcappedseleniumnanoparticles
AT zhipengliu antiamyloidogenicpropertiesof5caffeoylquinicacidcappedseleniumnanoparticles
AT varenyamachal antiamyloidogenicpropertiesof5caffeoylquinicacidcappedseleniumnanoparticles
AT olivierhabimana antiamyloidogenicpropertiesof5caffeoylquinicacidcappedseleniumnanoparticles